Used in vaccine development and diagnostic assays to detect neutralizing antibodies against the Omicron BA.4 variant of SARS-CoV-2. Enables study of spike protein interactions with the ACE2 receptor, supporting research on viral entry and immune response. Employed in serological testing to evaluate vaccine efficacy and in therapeutic antibody screening to identify effective binders targeting the mutated spike epitopes.